BIXT — Bioxytran Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro CapMomentum Trap
- $56.86m
- $59.23m
- 17
- 34
- 62
- 30
Annual cashflow statement for Bioxytran, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.318 | -0.296 | -1.86 | -2.54 | -4.53 |
| Depreciation | |||||
| Non-Cash Items | 0.222 | 0.078 | 1.31 | 1.18 | 0.66 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.06 | 0.033 | 0.121 | 0.263 | 2.17 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -0.019 | -0.186 | -0.431 | -1.1 | -1.7 |
| Capital Expenditures | — | — | — | -0.01 | -0.037 |
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0 | 0 | — | — | — |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | 0 | — | -0.01 | -0.037 |
| Financing Cash Flow Items | — | — | — | 0.95 | 0.6 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.023 | 0.222 | 0.564 | 0.981 | 1.76 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.004 | 0.036 | 0.133 | -0.128 | 0.031 |